Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours-Reference-Cited by-同舟云学术

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

Published:2000-01 Issue:1 Volume:36 Page:128-136
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Szepeshazi K.,Schally A.V.,Groot K.,Armatis P.,Hebert F.,Halmos G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Cancer Statistics, 1998;Landis;CA Cancer J. Clin.,1998

2. Surgical management of pancreatic carcinoma;McGrath;Semin. Oncol.,1996

3. No standard treatment is available for advanced pancreatic cancer;Lionetto;Eur. J. Cancer,1995

4. Hormonal therapy of pancreatic carcinoma;Perilli;Int. J. Pancreatol.,1993

5. Hypothalamic hormones;Schally;Anti-Cancer Drugs,1994

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches;Molecules;2022-04-21

2. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target;Proceedings of the National Academy of Sciences;2020-03-10

3. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone;British Journal of Haematology;2018-04-16

4. Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers;Journal of Controlled Release;2018-01

5. Molecular challenges of neuroendocrine tumors (Review);Oncology Letters;2017-12-21